Adaptimmune Therapeutics (ADAP)
(Real Time Quote from BATS)
$1.14 USD
+0.13 (12.87%)
Updated May 31, 2024 02:24 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Adaptimmune Therapeutics PLC [ADAP]
Reports for Purchase
Showing records 41 - 60 ( 123 total )
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
3Q21: Lead Product Topline Data Soon; New Trials to Begin in 2022
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Second Generation TCRs Reduce Solid Tumors - Data from ESMO
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Allogeneic T-Cell Therapy Update Following Collaboration with Genentech
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
AFP-Targeting TCR Therapy is Active in Liver Cancer Patients
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Collaboration with Genentech: Testament to Adaptimmune''s T-cell Expertise
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
2Q21: Very Busy 2H with Several Clinical Read-Outs in Solid Tumors
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
Company: Adaptimmune Therapeutics PLC
Industry: Medical - Biomedical and Genetics
1Q21: Several Clinical Readouts in 2021 Could be a Big HiT
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T